Julien de Salaberry, MBA

About

Healthcare has never had more innovation—or more uncertainty. Yet too many strategic decisions are still driven by fragmented information, hype and incomplete evidence. Every day, healthcare leaders make critical decisions about which technologies to invest in, which companies to partner with, which markets to enter and where AI can genuinely create value. Yet too many of these decisions are still driven by fragmented information, hype or incomplete evidence. For more than three decades, I have helped healthcare organisations make better innovation decisions. Today, that mission is embodied in HealthTech Alpha. I am the Founder and CEO of Galen Growth and the creator of HealthTech Alpha—a decision intelligence platform that helps pharmaceutical companies, medical technology companies, health systems, investors, and consultants identify, evaluate, and monitor the companies shaping the future of healthcare. For more than 30 years, I have worked at the intersection of healthcare, strategy, investment and innovation. Before founding Galen Growth, I held international leadership roles at Merck & Co., Eli Lilly, Boston Scientific, Baxter, GSK, Capgemini, and Lehman Brothers across Europe, the Middle East, and Asia-Pacific. Today, our clients use HealthTech Alpha to support decisions across: • Corporate Innovation • Strategic Partnerships • Venture Investing • M&A and Due Diligence • Competitive Intelligence • Ecosystem Strategy • AI and Digital Health My research and commentary focus on one question: How can healthcare organisations make faster, better and more confident innovation decisions? I regularly advise senior executives, investors and boards, speak at international conferences and publish evidence-based research on healthcare innovation, AI and digital health. If you're responsible for innovation, strategy, partnerships or investment in healthcare, I'd be delighted to connect. Decision Intelligence for Healthcare Innovation.

Roles

Companies

Activity